Innovative research with the potential to transform the diagnosis and management of acute stroke is set for a boost, with the Stroke Society of Australasia (SSA) calling for applications for a major new research grant.
The inaugural SSA-Boehringer Ingelheim Acute Stroke Research Innovation Grant offers $40,000 to an early-to-mid-stage researcher or healthcare professional seeking to deliver ground-breaking research to improve the diagnosis and management of acute stroke.
Managed independently by the SSA Scientific Committee through an unrestricted research grant from Boehringer Ingelheim, applications will be considered against the criteria that the research can deliver publishable outcomes within 18-24 months relating to novel techniques in stroke diagnostics or medical therapeutics in stroke.
“Stroke is one of Australia’s biggest killers and the leading cause of disability,” said SSA 2019 Scientific Committee Chair Professor Mark Parsons from the Royal Melbourne Hospital’s Department of Neurology. “We must continue to support research that may reveal new insights relating to stroke prevention, risk factors, diagnosis, treatment and recovery.
“The Stroke Society of Australasia is proud to help facilitate high quality, innovative medical research and to support stroke research leaders of the future.
“I encourage the many talented clinicians and researchers across Australia to embrace the spirit of innovation as they present research proposals to tackle the enormous burden of stroke.”
Boehringer Ingelheim Managing Director Wes Cook referenced the company’s “long and proud heritage in the prevention and treatment of stroke”.
“Australia is leading the world in stroke research and this grant is a wonderful example of how we can work together to find the next scientific breakthrough to advance stroke care,” he said.
The recipient of the grant will be announced at the 29th Annual Scientific Meeting of SSA in Canberra on September 13. Applications close on August 2.